Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Blood Cancer J
Hoofdauteurs: Caocci, Giovanni, Mulas, Olga, Capodanno, Isabella, Abruzzese, Elisabetta, Iurlo, Alessandra, Luciano, Luigiana, Albano, Francesco, Annunziata, Mario, Tiribelli, Mario, Bonifacio, Massimiliano, Galimberti, Sara, Castagnetti, Fausto, Sgherza, Nicola, Stagno, Fabio, Gozzini, Antonella, Orlandi, Ester Maria, Luzi, Debora, Binotto, Gianni, Pregno, Patrizia, Fozza, Claudio, Efficace, Fabio, Simula, Maria Pina, Trawinska, Malgorzata Monika, Cattaneo, Daniele, De Gregorio, Fiorenza, Attolico, Immacolata, Stella, Rossella, Scaffidi, Luigi, Baratè, Claudia, Gugliotta, Gabriele, Scalzulli, Emilia, Elena, Chiara, Pirillo, Francesca, Foà, Robin, Breccia, Massimo, Nasa, Giorgio La
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group UK 2020
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7280258/
https://ncbi.nlm.nih.gov/pubmed/32514110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-020-0333-2
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items